Clinical and Molecular Features of Patients With Congenital Disorders of Glycosylation in Japan. [PDF]
Okamoto N, Kadoya M, Wada Y.
europepmc +1 more source
Impact of COVID-19 infection in patients with inherited metabolic diseases: a National Multicenter Study from the French IMDs Healthcare Network for Rare Diseases. [PDF]
Douillard C +24 more
europepmc +1 more source
Advancement in Clinical Glycomics and Glycoproteomics for Congenital Disorders of Glycosylation: Progress and Challenges Ahead. [PDF]
Abu Bakar N, Hamzan NI.
europepmc +1 more source
Causes of mortality in the congenital disorders of glycosylation. [PDF]
Alharbi H +7 more
europepmc +1 more source
KIAA0319 modulates Alzheimer's disease risk through PMM2 regulation: Evidence from integrated pQTL-mediation and transcriptomic analyses. [PDF]
Wen P, Han C, Zhao H, Yao S, Chen H.
europepmc +1 more source
O-GlcNAcylation modulates expression and abundance of N-glycosylation machinery in an inherited glycosylation disorder. [PDF]
Matheny-Rabun C +10 more
europepmc +1 more source
Letter to the Editor Response. [PDF]
Nomura Y +6 more
europepmc +1 more source
Endocrine Implications of Congenital Disorders of Glycosylation [PDF]
Ünsal Y, Özön ZA.
europepmc +1 more source
Plasma membrane calcium ATPases and cerebellar pathology: what's the role in the ataxia? [PDF]
Peggion C +4 more
europepmc +1 more source
Neurodevelopmental profiles of 14 individuals with phosphomannomutase deficiency (PMM2-CDG). [PDF]
Weixel T +6 more
europepmc +1 more source

